BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that researchers from Kresge Eye Institute, Wayne State University and Detroit Mercy School of Dentistry, Detroit, MI are presenting new data on Tß4’s ability to down-regulate inflammation in the eye at the Third Biennial Military Vision Research Symposium: Traumatic Eye and Brain Injury on September 16-18, 2008 at the Schepens Eye Research Institute, an affiliate of Harvard University, Boston, MA. The data further elaborate Tß4’s ability to suppress inflammation stimulated and mediated by specific inflammatory molecules and pathways.
